1. Home
  2. PRCH vs ZURA Comparison

PRCH vs ZURA Comparison

Compare PRCH & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Porch Group Inc.

PRCH

Porch Group Inc.

HOLD

Current Price

$8.95

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$4.47

Market Cap

252.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRCH
ZURA
Founded
2012
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
252.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PRCH
ZURA
Price
$8.95
$4.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$17.56
$11.38
AVG Volume (30 Days)
1.4M
434.3K
Earning Date
11-05-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$442,483,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.06
N/A
P/E Ratio
$33.40
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.72
$0.97
52 Week High
$19.44
$4.68

Technical Indicators

Market Signals
Indicator
PRCH
ZURA
Relative Strength Index (RSI) 34.36 67.07
Support Level $8.85 $4.00
Resistance Level $9.28 $4.58
Average True Range (ATR) 0.50 0.24
MACD 0.09 0.05
Stochastic Oscillator 6.13 90.45

Price Performance

Historical Comparison
PRCH
ZURA

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

Share on Social Networks: